Bioptik Technology Incorporation (4161.TWO)

TWD 31.6

(-2.17%)

Market Cap (In TWD)

1.67 Billion

Revenue (In TWD)

828.5 Million

Net Income (In TWD)

85.71 Million

Avg. Volume

149.11 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
27.5-39.55
PE
-
EPS
-
Beta Value
0.3
ISIN
TW0004161005
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Healthcare
CEO
Mr. Jin-Chang Yang
Employee Count
-
Website
https://www.bioptik.com.tw
Ipo Date
2012-06-20
Details
Bioptik Technology Incorporation engages in the production and sale of medical devices and reagents worldwide. It offers EasyMate blood glucose monitoring systems; blood glucose/cholesterol/uric acid monitoring systems and its strips; and hyaluronic acid skin care products. The company also provides skin care products and dietary supplements, as well as biodiesel products. Bioptik Technology Incorporation was founded in 1999 and is based in Zhunan, Taiwan.